---
figid: PMC9354681__fonc-12-931371-g001
figtitle: CDK 4/6 inhibitors for the treatment of meningioma
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC9354681
filename: fonc-12-931371-g001.jpg
figlink: /pmc/articles/PMC9354681/figure/f1/
number: F1
caption: Schematic showing basic cyclin-CDK signaling pathway and mechanism of action
  of CDK inhibitors Made in BioRender.
papertitle: CDK 4/6 inhibitors for the treatment of meningioma.
reftext: Jacob S. Young, et al. Front Oncol. 2022;12:931371.
year: '2022'
doi: 10.3389/fonc.2022.931371
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: CDK inhibitor | meningioma | cell cycle dysregulation | clinical trials
  | molecular profiling and subtyping
automl_pathway: 0.9438542
figid_alias: PMC9354681__F1
figtype: Figure
redirect_from: /figures/PMC9354681__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9354681__fonc-12-931371-g001.html
  '@type': Dataset
  description: Schematic showing basic cyclin-CDK signaling pathway and mechanism
    of action of CDK inhibitors Made in BioRender.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cdkn2a
  - Cyp2b10
  - Rbm14
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Cdk4
  - Gabrg2
  - CDKN2A
  - H3P10
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK4
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - WARS1
  - Zdhhc8
  - Arpc5
  - Su(osk)P16
  - dap
  - ebi
  - E2f2
  - E2f1
  - Drice
  - CycE
  - cyc
  - rb
  - mo
  - anon-70Dc
---
